Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Piezo-type mechanosensitive ion channel component 1 pseudogene 2 (PIEZO1P2)
- Target
- PIEZO1P2
- Molecular classification
- Pseudogene, Non-coding RNA (potential, if transcribed)
01
Overview
PIEZO1P2 (Piezo-type mechanosensitive ion channel component 1 pseudogene 2) is a human pseudogene related to the PIEZO1 gene, which encodes a large, multi-pass membrane protein functioning as a mechanosensitive ion channel[3]. Pseudogenes, by definition, are gene copies that have lost their protein-coding potential, typically through mutations or truncations. PIEZO1P2 does not produce a functional protein and has not been shown to play a regulatory role in gene expression, disease, or as a therapeutic target. Unlike its parental gene PIEZO1, which is implicated in mechanotransduction processes, PIEZO1P2 appears to be biologically inert, with no known function, clinical significance, or utility as a drug target[2][1][3].
- Other names
- Piezo-type mechanosensitive ion channel component 1 pseudogene 2PIEZO1P2
02
Biological functions
Other (pseudogenes can sometimes regulate gene expression through mechanisms such as acting as competitive endogenous RNAs, but for PIEZO1P2, no such functional role is described)
03
Disease associations
Other (no documented role for PIEZO1P2 in disease currently; pseudogenes in general may have regulatory roles or be relevant in cancer, but this has not been described for PIEZO1P2 specifically)
Beyond the preview
Go deeper on Piezo-type mechanosensitive ion channel component 1 pseudogene 2 (PIEZO1P2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Piezo-type mechanosensitive ion channel component 1 pseudogene 2 (PIEZO1P2).